You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》诺辉健康(06606.HK)公开超购4,132倍及上限定价 一手中签率2%
阿思达克 02-17 08:20
诺辉健康-B(06606.HK)公布招股结果,计划发行7,659.8万股,原先约10%为本地公开发售,公开发售录超购4,132.19倍,经重新分配後,公开发售股数增至50%。国际发售初步提呈发售的发售股份获大幅超额认购,相当於国际发售初步

可供认购总数约64.16倍。

每股发售价定於26.66元,为上限定价(招股价介乎每股22.7至26.66元),一手500股中签率仅2%。该股将於明日(2月18日)挂牌上市,联席保荐人为高盛及瑞银。

是次招股引入16名基石投资者,包括景顺、清池资本、博裕、GIC、加皇环球资产管理、Columbia Funds、骏利亨德森资产管理、Rock Springs Capital Master Fund LP、Worldwide Healthcare Trust PLC、礼来亚洲旗下LAV Amber Limited、Cormorant Global、HBC Asia Healthcare Opportunities VII LLC、Octagon Investments Master Fund LP、Sage Partners Master Fund、南方基金管理及E Fund,占公司紧随全球发售完成後已发行股本约8.63%。

公司预计,所得款项净额约为18.99亿元,当中约40%用於为产品「常卫清」的商业化及进一步开发提供资金;约30%用於为正在进行及计划进行的早期阶段管线产品研发提供资金;约15%将用於潜在收购或外部引进癌症筛查领域的候选产品;约5%用於为产品「噗噗管」的持续销售及营销提供资金;以及约10%为一般营运资金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account